Neovasc Inc. (TSE:NVC – Get Free Report) (NASDAQ:NVCN) rose 2.3% on Monday . The company traded as high as C$1.82 and last traded at C$1.78. Approximately 46,869 shares changed hands during trading, a decline of 58% from the average daily volume of 111,876 shares. The stock had previously closed at C$1.74.
Neovasc Stock Performance
The firm’s 50-day moving average price is C$1.78.
About Neovasc
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
Further Reading
- Five stocks we like better than Neovasc
- Pros And Cons Of Monthly Dividend Stocks
- Rocket Lab is the Right Stock for the Right Time
- Investing In Preferred Stock vs. Common Stock
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.
